Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.5 USD | -0.36% | -4.89% | +3.89% |
28/06 | GSK reaches settlement over Zantac case in Illinois | AN |
28/06 | GSK Reaches Settlement in Illinois Zantac Lawsuit | DJ |
Business Summary
Number of employees: 70,212
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Commercial Operations
100.0
%
| 29,324 | 100.0 % | 30,328 | 100.0 % | +3.42% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
52.2
%
| 14,542 | 49.6 % | 15,820 | 52.2 % | +8.79% |
Rest of World
45.6
%
| 14,087 | 48.0 % | 13,815 | 45.6 % | -1.93% |
United Kingdom
2.3
%
| 695 | 2.4 % | 693 | 2.3 % | -0.29% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 01/10/01 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 01/23/01 |
James Ford
CMP | Compliance Officer | - | 01/95/01 |
Amy Altshul
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01/18/01 | |
Tony Wood
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Hal Barron
BRD | Director/Board Member | 62 | 01/18/01 |
David Redfern
PRN | Corporate Officer/Principal | 57 | 01/94/01 |
Frannie DeFranco
PRN | Corporate Officer/Principal | - | 01/10/01 |
Claire Lund
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 01/23/01 |
Jonathan Symonds
CHM | Chairman | 66 | 01/19/01 |
Hal Barron
BRD | Director/Board Member | 62 | 01/18/01 |
Vishal Sikka
BRD | Director/Board Member | 57 | 18/22/18 |
Wendy Becker
BRD | Director/Board Member | 58 | 01/23/01 |
Charles Bancroft
BRD | Director/Board Member | 65 | 01/20/01 |
Anne Beal
BRD | Director/Board Member | 62 | 06/21/06 |
Emma Walmsley
CEO | Chief Executive Officer | 55 | 01/10/01 |
Director/Board Member | 66 | 01/22/01 | |
Jesse Goodman
BRD | Director/Board Member | 72 | 01/16/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,314,134,937 | 4,078,341,204 ( 94.53 %) | 169,171,155 ( 3.921 %) | 94.53 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
127,054,524 | 75.00% | 4,004,128,406 $ | |
HALEON PLC 4.22% | 385,320,110 | 4.22% | 1,594,905,440 $ |
263,029,794 | 82.59% | 119,134,085 $ | |
HALEON PAKISTAN LIMITED 85.79% | 100,423,259 | 85.79% | 91,315,874 $ |
VIR BIOTECHNOLOGY, INC. 6.28% | 8,550,954 | 6.28% | 87,818,298 $ |
WAVE LIFE SCIENCES LTD. 11.42% | 13,983,761 | 11.42% | 86,419,643 $ |
LYELL IMMUNOPHARMA, INC. 11.87% | 30,253,189 | 11.87% | 83,801,334 $ |
CUREVAC N.V. 7.40% | 16,591,937 | 7.40% | 64,542,635 $ |
GLAXOSMITHKLINE S.A.E 91.20% | 76,161,378 | 91.20% | 45,239,859 $ |
BICYCLE THERAPEUTICS PLC 4.03% | 1,529,561 | 4.03% | 33,940,959 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
GlaxoSmithKline Asia Pvt Ltd.
GlaxoSmithKline Asia Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Asia Pvt Ltd. is an Indian company that produces bacterial and virus vaccines and other pharmaceutical products. The company is based in Gurgaon, India. |
Pharmaceuticals: Major
|
GlaxoSmithKline GmbH & Co. KG
GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline GmbH & Co. KG is a German pharmaceutical company. The company is based in Munich, Germany. The CEOs of the company are Jean-Bernard Siméon, Adrian Bauer. |
Pharmaceuticals: Major
|
Glaxosmithkline Investment Services Ltd.
Glaxosmithkline Investment Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Glaxosmithkline Investment Services Ltd. provides business support services. The company is based in Middlesex, UK and was founded in 2009. |
Miscellaneous Commercial Services
|
SmithKline Beecham (Cork) Ltd.
SmithKline Beecham (Cork) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, SmithKline Beecham (Cork) Ltd. is an Irish pharmaceutical company that manufactures pharmaceutical products. The company is based in Carrigaline, Ireland. |
Pharmaceuticals: Major
|
GlaxoSmithKline Insurance Ltd.
| |
GlaxoSmithKline Trading Services Ltd.
GlaxoSmithKline Trading Services Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Trading Services Ltd. is an Irish company that manufactures and wholesales pharmaceutical products. The company is based in Dublin, Ireland. |
Pharmaceuticals: Major
|
GSK Consumer Healthcare Capital US LLC
GSK Consumer Healthcare Capital US LLC Medical/Nursing ServicesHealth Services Part of Haleon Plc, Haleon US Capital LLC is a company that provides healthcare services. Haleon US Capital LLC is based in Wilmington, DE. |
Medical/Nursing Services
|
GlaxoSmithKline Holdings (Ireland) Ltd.
GlaxoSmithKline Holdings (Ireland) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Holdings (Ireland) Ltd. provides financial management services. The company is based in Brentford, UK. Founded in 2014. |
Miscellaneous Commercial Services
|
GlaxoSmithKline Services Unlimited
GlaxoSmithKline Services Unlimited Pharmaceuticals: MajorHealth Technology Glaxosmithkline Services Unlimited Ltd. develops, manufactures and markets pharmaceutical products. The company was incorporated on March 23, 1972 and is headquartered in Brentford, the United Kingdom. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- GSK Stock
- GSK Stock
- Company GSK plc